Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Avadel Pharmaceuticals plc (AVDL) will participate in upcoming investor conferences to discuss their biopharmaceutical endeavors. The company aims to transform medicines and lives through its innovative approach.
03/05/2024 - 08:00 AM
DUBLIN, Ireland, March 05, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences:
Leerink Global Biopharma Conference: Fireside chat on Monday, March 11 at 3:20 p.m. ET. UBS Virtual CNS Day: Fireside chat on Monday, March 18 at 12:30 p.m. ET. A live webcast of these events, as well as an archived recordings, will be available on Avadel’s Investor Relations website, investors.avadel.com , for 90 days following each conference.
About Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZ™, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. For more information, please visit www.avadel.com .
Investor Contact: Courtney Mogerley Stern Investor Relations, Inc.Courtney.Mogerley@sternir.com (212) 698-8687
Media Contact: Lesley Stanley Real Chemistry lestanley@realchemistry.com (609) 273-3162
When is Avadel Pharmaceuticals plc (AVDL) participating in the Leerink Global Biopharma Conference?
Avadel Pharmaceuticals plc (AVDL) will have a fireside chat at the Leerink Global Biopharma Conference on Monday, March 11 at 3:20 p.m. ET.
What is the schedule for Avadel Pharmaceuticals plc (AVDL) at the UBS Virtual CNS Day?
Avadel Pharmaceuticals plc (AVDL) will have a fireside chat at the UBS Virtual CNS Day on Monday, March 18 at 12:30 p.m. ET.
Where can investors access the live webcast and archived recordings of Avadel Pharmaceuticals plc (AVDL) events?
Investors can access the live webcast and archived recordings of Avadel Pharmaceuticals plc (AVDL) events on the company's Investor Relations website, investors.avadel.com, for 90 days after each conference.
Avadel Pharmaceuticals plc
AVDL Rankings
#397 Ranked by Stock Gains
AVDL Stock Data
Industry
Medicinal and Botanical Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Medicinal and Botanical Manufacturing
Country
Ireland
City
Dublin
About AVDL
avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.